Glyconics and Ieso Digital Health in global hot 100
Business Weekly Awards shortlisted company Glyconics was recently included in the Journal of Mhealth Global Digital Health Top 100 companies.
Glyconics is a Cambridge-based medical diagnostic company developing hand-held infrared spectroscopy devices for point-of-care testing and monitoring.
CEO Kam Pooni said: “This is a real achievement for the team. I’m proud to call myself chief executive of such an exciting and growing company.
“The Global Digital Health 100 is one of the HealthTech industry’s foremost technology award programmes, celebrating innovation and entrepreneurship. It recognises and supports health technology companies that are demonstrating the greatest potential to change the way that healthcare is delivered.”
Two other prominent Cambridge companies are featured in the rankings – Congenica and Ieso Digital Health. The latter is also shortlisted in the Business Weekly Awards.
Congenica is the provider of the diagnostic decision support platform, Sapientia, and associated clinical services, which enable clinicians to interrogate the human genome to identify disease-causing variants.
Ieso is a world leading digital health company specialising in Internet enabled evidence-based psychological therapies.
Ieso use proprietary technology, augmented with natural language processing and artificial intelligence, to amplify therapy outcomes for patients while providing personalised training and supervision for therapists. This generates higher recovery rates and better outcomes for patients, while also delivering cost savings for the wider health economy.
For the full A-Z, visit https://thejournalofmhealth.com/digital-health-100/